Загрузка...
Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections
Rituximab targets normal B cells and tumor B cells. We used a unique data-mining tool to identify patients with lymphoma who were treated with rituximab and who had serial pre and post rituximab immunoglobulin concentrations evaluated. After treatment, 39% (69/179) of patients had low levels of immu...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4035033/ https://ncbi.nlm.nih.gov/pubmed/23276889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2012.11.011 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|